Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study.
Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Rautanen A, Gordon AC, Garrard C, Hill AV, Hinds CJ, Knight JC. · 2016
Read Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. by Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Rautanen A, Gordon AC, Garrard C, Hill AV, Hinds CJ, Knight JC. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4820667.txt.
Description
Emma E. Davenport leads a twelve-author team in The Lancet Respiratory Medicine in 2016 splitting sepsis patients by their gene activity. Sepsis care has no targeted drug, partly because patients' immune replies differ wildly. The team read the full gene activity of blood cells from 265 intensive care patients with sepsis from lung infection, then checked the pattern in 106 more.
Two response signatures emerged. One, found in about four in ten patients, showed a suppressed immune system: tolerant to bacterial toxins, with worn-out T cells and dimmed display molecules. Those patients died at about two and a half times the rate of the other group within two weeks. A seven-gene test could sort patients, and gene variants that tune the response were also mapped. The split, the authors argue, is the map targeted sepsis therapy needs.
Catalog record
| CREATOR | Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Rautanen A, Gordon AC, Garrard C, Hill AV, Hinds CJ, Knight JC. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |